Novartis reported CHF29.88B in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Alcon AG ALC:SW 2.38B 172M
Amgen AMGN:US $ 14842M 257M
AstraZeneca AZN:LN 23649M 1427M
Bayer BAYN:GR € 28727M 801M
Biogen BIIB:US $ 4211.6M 864.4M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Eli Lilly And LLY:US $ 13682M 1411.2M
Fresenius FRE:GR € 15352M 148M
Fresenius Medical Care FME:GR € 7492M 67.37M
Galapagos GLPG:NA € 575.49M 1.49M
Genmab GEN:DC DK 1830M 479M
Gilead Sciences GILD:US $ 10245M 31M
GlaxoSmithKline GSK:LN 22417M 1030M
GRIFOLS GRF:SM € 1921.48M 360.62M
H. Lundbeck A/S LUN:DC 9.08B 646M
Hikma Pharmaceutical HIK:LN 960M 68M
Lonza Group LONN:SW 3.11B 12M
Merck MRK:GR € 9793M 27M
Novartis NVS:US $ 29880M 247M
Novartis NOVN:VX SF 29880M 247M
Orion ORNBV:FH € 154.3M 25.5M
Recordati REC:IM € 610.64M 24.27M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M